Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery?

Interactive Cardiovascular and Thoracic Surgery

Volumn 5, Issue 6, 2006, Pages 774-778

  Leite, Eduardo Guilherme ^a   Ronald, Andrew ^b   Rodrigues, Alfredo J ^a   Evora, Paulo Roberto B ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c NONE   (Brazil)

Author keywords

Cardiopulmonary bypass; cGMP; Guanylate cyclase; Methylene blue; Vasoplegic syndrome

Indexed keywords

CATECHOLAMINE; METHYLENE BLUE;

ARTICLE; CORONARY ARTERY BYPASS GRAFT; EVIDENCE BASED MEDICINE; HEART SURGERY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VASCULAR DISEASE; VASOPLEGIC SYNDROME;

EID: 33845449178     PISSN: 15699293     EISSN: 15699293     Source Type: Journal    
DOI: 10.1510/icvts.2006.134726     Document Type: Article

References (19)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact Cardiovasc Thorac Surg 2003;2:405-409.
2. Gomes WJ, Carvalho AC, Palma JH, Goncalves Jr I, Buffolo E. Vasoplegic syndrome: a new dilemma. J Thorac Cardiovasc Surg 1994;107:942-943.
3. Gomes WJ, Carvalho AC, Palma JH, Teles CA, Branco JN, Silas MG, Buffolo E. Vasoplegic syndrome after open heart surgery. J Thorac Cardiovasc Surg 1998;39:619-623.
4. Gomes WJ, Erlichman MR, Batista-Filho ML, Knobel M, Almeida DR, Carvalho AC, Catani R, Buffolo E. Vasoplegic syndrome after off-pump coronary artery bypass surgery. Eur J Cardiothorac Surg 2003;23:165-169.
5. Shanmugam G. Vasoplegic syndrome - the role of methylene blue. Eur J Cardiothorac Surg 2005;28:705-710.
6. Faber P, Ronald A, Millar BW. Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass. Anaesthesia 2005;60:575-587.
7. Evora PRB, Viaro F. The guanylyl cyclase inhibition by MB as vasoplegic circulatory shock therapeutic target. Current Drug Targets 2006 (In press).
8. Andrade JCS, Batista Filho ML, Evora PRB, Tavares JR, Buffolo E, Ribeiro EE, Silva LA, Teles CA, Petrizzo A, Barata F, Vitor V, Duprat R. Methylene blue administration in the treatment of the vasoplegic syndrome after cardiac surgery. Revista Brasileira de Cirurgia Cardiovascular (Rev Bras Cir Cardiovasc) 1996;11:107-114.
9. Dagenais F, Mathieu P. Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery. Can J Cardiol 2003;19:167-169.
10. Grayling M, Deakin CD. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis. J Thorac Cardiovasc Surg 2003;125:426-427.
11. Kofidis T, Struber M, Wilhelmi M, Anssar M, Simon A, Harringer W, Haverich A. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thorac Cardiovasc Surg 2001;122:823-824.
12. Pagni S, Austin EH. Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2000;119:1297-1298.
13. Yiu P, Robin J, Pattison CW. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery. J Thorac Cardiovasc Surg 1999;118:195-196.
14. Evora PRB, Rodrigues AJ. Methylene blue revised. J Thorac Cardiovasc Surg 2006;131:250-251.
15. Sparicio D, Landoni G, Pappalardo F, Crivellari M, Cerchierini E, Marino G, Zangrillo A. Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases. J Thorac Cardiovasc Surg 2004;127:592-593.
16. Riha H, Rihova L, Pind'ak M, Brezina A, Pirk J. Methylene blue in the therapy of vasoplegic syndrome after cardiac surgery procedure. [Czech] Casopis Lekaru Ceskych 2006;145:322-324.
17. Leyh RG, Kofidis T, Struber M, Fischer S, Knobloch K, Wachsmann B, Hagl C, Simon AR, Haverich A. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg 2003;125:1426-1431.
18. Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, Boullon FJ. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004;77:496-499.
19. Ozal E, Kuralay E, Yildirim V, Kilic S, Bolcal C, Kucukarslan N, Gunay C, Demirkilic U, Tatar H. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg 2005;79:1615-1619.